Cardiothoracic & vascular anesthesia

Vasoplegic Syndrome during Left Ventricular Assist Device Insertion: A Systematic Review and Meta-Analysis

J Cardiothorac Vasc AnesthPublished Systematic review and meta-analysis of retrospective studies

Authors' conclusion

VS affects approximately one-third of LVAD recipients and is associated with substantially increased postoperative morbidity and mortality.

Study context

Population
Adults undergoing durable left ventricular assist device (LVAD) insertion via cardiopulmonary bypass (CPB)
Participants
3,121 adults · 16 retrospective studies
Comparison
Vasoplegic syndrome (VS) vs no VS after durable LVAD insertion
  • VSn = 1,093
Outcome
Pooled VS incidence
Methodological detailsPRISMA, Newcastle-Ottawa Scale risk of bias
  • PRISMA
  • Newcastle-Ottawa Scale risk of bias

Pooled result

As reported in the abstract

Pooled VS incidence

36.30%

95% CI 34.61%–38.02%

Further pooled results

Risk factors for VS

RRP value
Male sex1.65P = 0.008
INTERMACS profile ≤21.19P = 0.009
Repeat sternotomy1.30P = 0.020
Concomitant procedures1.27P = 0.003
OutcomeNo VSWMD (minutes)P value
Risk factors for VSLonger CPB duration13.17P < 0.001
ICU LOSVS vs No VS6.34 daysP < 0.001
Mortality · 30 daysVS vs No VS5.63%P < 0.001
Mortality · 1 yearVS vs No VS22.62%P = 0.030
  • ICU LOS: VS 10.00 days
  • Mortality: VS 14.85%
  • Mortality: VS 33.88%

Safety

OutcomeORP value
Postoperative complicationsVS vs No VS · right ventricular failure1.76P < 0.001
Postoperative complicationsVS vs No VS · RRT1.77P < 0.001
Postoperative complicationsVS vs No VS · reoperation for bleeding2.46P < 0.001

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Vasoplegic Syndrome during Left Ventricular Assist Device Insertion: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth. Published 13 July 2026. doi:10.1053/j.jvca.2026.07.021

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.